Demucin

Indonesia • Dexa Medica

Indication

Secretolytic therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.

Composition

Each ml contains:
Bromhexine hydrochloride 2 mg

Package

Box, 5 ampoules x 2 ml

Dosage Forms

Injection

ATC Classification

R05C

Warning

Alcohol
Consult Your Doctor
Safety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
Safe if Prescribed
This item is safe for use while operating heavy machinery.
Pregnancy
Consult Your Doctor
Safety of this item for use during pregnancy has not been established. Please consult your doctor.
Lactation
Consult Your Doctor
Safety of this item for use during lactation has not been established. Please consult your doctor.
Precaution

There have been reports of severe skin reactions such as erythema multiforme, Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP) associated with the administration of bromhexine hydrochloride. Mostly these could be explained by the patient’s underlying disease and/or concomitant medication. In addition, during the early phase of Stevens-Johnson syndrome or TEN, a patient can first experience nonspecific influenza-like prodomes like e.g. fever, aching body, rhinitis, cough, and sore throat. Misled by these nonspecific influenza-like prodomes it is possible that a symptomatic treatment is started with a cough and cold medication.

If symptoms or signs of a progressive skin rash (sometimes associated with blisters or mucosal lesions) are present, bromhexine hydrochloride treatment should be discontinued immediately and medical advice should be sought.

Dosage

In severe cases as well as before and after surgical intervention, 1 ampoule IV (duration of injection 2–3 minutes) 2–3 times daily.

The injection can also be given as an IV infusion.

* For detailed product information, see package insert.